Company intelligence / Profile preview

Sojitz

Chiyoda-ku, Tokyo, Japansojitz.com ↗

Ownership: Private
Employees: ~25118
Development stage: Other

Overview

Sojitz is a major Japanese general trading company engaged globally across multiple sectors including chemicals, energy solutions, healthcare service provision, environmental/life science businesses, and more. In the life sciences/biotech space specifically, it acts as an investor/enabler—supporting bioeconomy initiatives through investments in DNA synthesis startups like Synplogen and partnerships to promote synthetic biology adoption via Ginkgo Bioworks. It also operates healthcare service businesses internationally but does not have its own therapeutic pipeline or clinical results to report[1][4][5][7].

Modalities: Enabling technologies (e.g., synthetic biology, DNA synthesis)
Industry: Investors

Partnerships

Ginkgo Bioworks (synthetic biology R&D collaboration)Synplogen Co., Ltd. (DNA synthesis startup investment)

Beyond the preview

Go deeper on Sojitz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sojitz.

Explore the full profile